Skip to main content

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology.

Diaz IM, Nocon A, Held SAE, Kobilay M, Skowasch D, Bronkhorst AJ, Ungerer V, Fredebohm J, Diehl F, Holdenrieder S, Holtrup F

Publication: Diagnostics (Basel) (2023) • Vol 13PMID: 37046506View on PubMed

Purpose

The purpose of this paper was to compare cell-free DNA (cfDNA) yield, the level of genomic DNA contamination, and mutation allele frequencies (MAFs) in plasma isolated from blood that was stored in K2EDTA tubes for 2 or 6 h and in Streck Cell-Free DNA blood collection tubes (BCTs) for 2 h or 3 days. The study used specimens from patients with colorectal cancer, pancreatic cancer, and non-small cell lung cancer (NSCLC).

Conclusion

cfDNA yields were comparable in plasma isolated from blood specimens collected from patients with colorectal cancer, pancreatic cancer, and NSCLC in to K2EDTA and Streck Cell-Free DNA blood collection tubes (Streck BCTs) that were analyzed after 2 h (both tube types), 6 h (K2EDTA tube only), and 3 days (Streck BCT only) at room temperature.  Further, the ratio of long (402 bp) to short (96 bp) fragments of long interspersed nuclear elements -1 (LINE-1) fragments was comparable when blood was stored in Streck BCTs for 2 h versus 3 days and when blood was stored inK2EDTA tubes for 2 versus 6 h, indicating blood storage for these durations did not increase the level of genomic DNA contamination or decrease cfDNA levels. A total of 16 mutations were in 15 specimens identified by beads, emulsion, amplification, magnetics (BEAMing) analysis (one specimen had two mutations). MAFs were similar between the tube types evaluated and the processing delays investigated.

Studies (1)

Purpose

The purpose of this study was to compare cfDNA yield, the level of genomic DNA contamination, and MAF in plasma isolated from blood that was stored in K2EDTA tubes for 2 or 6 h and in Streck Cell-Free DNA blood collection tubes (BCTs) for 2 h or 3 days. The study used specimens from patients with colorectal cancer, pancreatic cancer and NSCLC. Case-matched blood was collected from 21 patients with colorectal cancer, 11 with pancreatic cancer, and 21 with non-small cell lung cancer (NSCLC) into K2EDTA tubes and Streck Cell-Free DNA BCTs. Plasma was separated from both tube types after 2 h, from K2EDTA tubes after 6 h at room temperature and from Streck Cell-Free DNA BCTs after 3 days by centrifugation at 1600 g for 10 min followed by 6000 g for 10 min. Plasma was aliquoted and stored at -80°C until DNA isolation using the QIAamp Circulating Nucleic Acid Kit and a modified protocol (extended Proteinase K digestion). DNA was quantified by real-time PCR of 96 and 402 bp fragments of LINE-1 and the ratio was used as a marker of genomic DNA contamination. The mutational load of isolated cfDNA was analyzed by BEAMing of common KRAS, NRAS, and EGFR mutations.

Summary of Findings

cfDNA yields were comparable in plasma isolated from blood collected from patients with colorectal cancer, pancreatic cancer and NSCLC in to K2EDTA tubes and Streck Cell-Free DNA BCTs that were analyzed after 2 h (both tube types), 6 h (K2EDTA tube only), and 3 days (Streck BCT only) at room temperature.  Further, the ratio of long (402 bp) to short (96 bp) LINE-1 fragments was comparable when blood was stored in Streck BCTs for 2 h versus 3 days and when blood was stored in K2EDTA tubes for 2 versus 6 h, indicating blood storage for these durations did not increase the level of genomic DNA contamination or decrease cfDNA levels. A total of 16 mutations were identified in 15 specimens by BEAMing analysis (one specimen had two mutations). MAFs were similar between the tube types evaluated and the processing delays investigated.  Further, MAF was very strongly correlated between specimens stored in K2EDTA tubes for 2 h and those stored in Streck BCTs for 2 h (R2=0.9768) or 3 days (R2=0.929) or in K2EDTA tubes for 6 h (R2=0.99923 in pancreatic cancer patients and R2=0.9957 in NSCLC patients).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    FrozenOther Preservative
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNAReal-time qPCR
    DNAFlow cytometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Colorectal cancer
    Non-small cell lung cancer
    Pancreatic cancer
    Biospecimen AcquisitionType of collection container/solution
    K2EDTA tube
    Streck Cell-Free DNA blood collection tube
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageTime at room temperature
    2 h
    3 days
    6 h
    Real-time qPCR SpecificLength of gene fragment
    402 bp LINE-1
    96 bp LINE-1